February 25, 2026
The investigational MDMA analogue, TSND-201 (methylone), significantly reduced posttraumatic stress disorder (PTSD) symptom severity compared with placebo in a phase 2 randomized, placebo-controlled trial, with effects […]
February 23, 2026
The FDA has approved milsaperidone (Bysanti, Vanda Pharmaceuticals) as first-line treatment for acute manic or mixed episodes associated with bipolar I disorder and for the treatment […]
February 23, 2026
Brief bouts of high-intensity exercise reduced panic disorder (PD) symptom severity more than relaxation therapy. Results of a randomized trial revealed that after 12 weeks of […]
February 23, 2026
TOPLINE: Extreme nighttime heat was linked to a significantly increased prevalence of suicidal help-seeking behavior in a new study, with a 19% increase at the 90th […]
February 20, 2026
TOPLINE: Insomnia affected up to 91% of individuals with alcohol use disorder (AUD), with evidence suggesting a bidirectional relationship. An 8-week day therapy programme led to […]
February 19, 2026
TOPLINE: The prevalence of anxiety or depression increased significantly between 2019 and 2023, especially for men, Black individuals, and people born outside the US, a new […]
February 19, 2026
England is in the throes of a mental health crisis of “pandemic proportion,” the Royal College of Psychiatrists (RCPsych) has warned, with many people unable to […]
February 18, 2026
Passively collected sleep and activity data detected early warning signs of depression relapse weeks before a full episode emerged, results of a longitudinal cohort study showed. […]
February 18, 2026
At the 38th Congress of the French Society for Rheumatology (SFR), held on December 14-16, 2025, in Paris, France, a session bringing together psychologists and rheumatologists […]